Device Trial Radar · NCT02097082
Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System
Last checked: Nov 20, 2026Latest source record: Sep 6, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Oct 2013
Primary completion
Mar 30, 2016
Study completion May 2017
Sponsor
- Lead sponsor
- 480 BiomedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 26, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
An evaluation of the safety and performance of the STANZA Drug-eluting Resorbable Scaffold (DRS) system for the treatment of patients with obstructive superficial femoral artery disease.
Conditions
- Peripheral Arterial Disease
- Intermittent Claudication
- Vascular Diseases
- Cardiovascular Diseases
Interventions
STANZA Drug-eluting resorbable ScaffoldDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Patency by UltrasoundTime frame: through 6 months
- Major Adverse EventsTime frame: 30 days
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
Universitäts Klinikum Graz
Graz, Austria
WGKK - Hanusch-Krankenhaus
Vienna, Austria
Cardiovascular and Interventional Radiology- AKH
Vienna, Austria
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.